BioCentury | Jul 11, 2016
Company News

Natera, Sequenom, Thermo Fisher, Roche diagnostic news

...cycles was not directed to a patent-ineligible law of nature in Rapid Litigation Management v. CellzDirect...
...claims do have an inventive application because they cover an improved process. Thermo Fisher owns CellzDirect Inc....
BioCentury | Jul 7, 2016
Politics & Policy

CAFC vacates decision that invalidated a process patent

...court's decision that had invalidated the patent. The CAFC decision in Rapid Litigation Management v. CellzDirect...
...to make them patent eligible (see BioCentury Extra, June 27) . In Rapid Litigation v. CellzDirect...
BioCentury | Oct 20, 2008
Company News

Invitrogen, Qualyst sales and marketing update

...Under a co-exclusive deal, Invitrogen's CellzDirect subsidiary will provide new hepatocyte screening services and research products...
BioCentury | Jan 14, 2008
Company News

CellzDirect, Invitrogen deal

...Invitrogen will acquire CellzDirect for about $57 million in cash. CellzDirect provides hepatocyte-based cell products for...
...complement its portfolio of complete cell systems. The deal is expected to close this quarter. CellzDirect Inc....
Items per page:
1 - 4 of 4
BioCentury | Jul 11, 2016
Company News

Natera, Sequenom, Thermo Fisher, Roche diagnostic news

...cycles was not directed to a patent-ineligible law of nature in Rapid Litigation Management v. CellzDirect...
...claims do have an inventive application because they cover an improved process. Thermo Fisher owns CellzDirect Inc....
BioCentury | Jul 7, 2016
Politics & Policy

CAFC vacates decision that invalidated a process patent

...court's decision that had invalidated the patent. The CAFC decision in Rapid Litigation Management v. CellzDirect...
...to make them patent eligible (see BioCentury Extra, June 27) . In Rapid Litigation v. CellzDirect...
BioCentury | Oct 20, 2008
Company News

Invitrogen, Qualyst sales and marketing update

...Under a co-exclusive deal, Invitrogen's CellzDirect subsidiary will provide new hepatocyte screening services and research products...
BioCentury | Jan 14, 2008
Company News

CellzDirect, Invitrogen deal

...Invitrogen will acquire CellzDirect for about $57 million in cash. CellzDirect provides hepatocyte-based cell products for...
...complement its portfolio of complete cell systems. The deal is expected to close this quarter. CellzDirect Inc....
Items per page:
1 - 4 of 4